SARS‐CoV‐2 re‐infection risk in Austria

BACKGROUND: A key question concerning coronavirus disease 2019 (COVID‐19) is how effective and long lasting immunity against this disease is in individuals who were previously infected with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). We aimed to evaluate the risk of SARS‐CoV‐2 re‐i...

Descripción completa

Detalles Bibliográficos
Autores principales: Pilz, Stefan, Chakeri, Ali, Ioannidis, John PA, Richter, Lukas, Theiler‐Schwetz, Verena, Trummer, Christian, Krause, Robert, Allerberger, Franz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988582/
https://www.ncbi.nlm.nih.gov/pubmed/33583018
http://dx.doi.org/10.1111/eci.13520

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988582/
https://www.ncbi.nlm.nih.gov/pubmed/33583018
http://dx.doi.org/10.1111/eci.13520

Ejemplares similares